Are there generic versions of Pitobrutinib/Pitobrutinib? Explore new medication options for patients!

Pirtobrutinib is a new type of non-covalent BTK inhibitor, which is used in the treatment of various B-cell malignancies (mantle cell lymphoma,

Currently in the international market, the original drug of pitobrutinib mainly comes from European and American countries. Common specifications include 50 mg × 30 tablets and 100 mg × 60 tablets. Because the drug is still under patent protection, the price is relatively high, with a box often costing tens of thousands of yuan, which is a heavy burden for patients who require long-term treatment. However, with the advancement of patent policy flexibility and generic drug regulations in some overseas countries, some countries have begun to produce and sell generic versions of pitobrutinib.

Among them, a well-known pharmaceutical company in Laos has launched a generic version of pitobrutinib, with a specification of 50 mg × 30 tablets. Its drug ingredients are basically the same as the original drug and meet the equivalence standards for generic drugs. The price of this version is relatively affordable, about several thousand yuan, which greatly reduces the patient's medication burden compared with the original drug. Judging from clinical use feedback, this generic version is not much different from the original drug in terms of efficacy and tolerability. It is especially suitable for patients who are under great financial pressure but urgently need the drug. For more information on overseas drug prices and related information, please consult Yaode Medical Consultant.

Reference materials:https://go.drugbank.com/drugs/DB17472